Portugal launches multidisciplinary clinical guidance on psychedelic therapies

On May 12, the Champalimaud Foundation hosted the official launch of Portugal’s Multidisciplinary Recommendations on the Clinical Use of Psychedelic Substances. This represents the culmination of nearly two years of public consultation and cross-sector work involving key national professional boards and coordinated by the Champalimaud Foundation.

The launch event in Lisbon brought together a remarkable coalition of stakeholders, including the Presidents of the

  • Portuguese Order of Physicians

  • Portuguese Order of Psychologists

  • Portuguese Order of Pharmacists

  • Portuguese Society of Psychiatry and Mental Health

  • National Council of Ethics for the Life Sciences

These recommendations are a milestone—not only for Portugal, but as an example of how cross-disciplinary collaboration can shape the future of psychedelic care.

For now, they are available only in Portuguese, with an English version forthcoming as part of a scientific publication.

Previous
Previous

“Leading not Lagging” - PAREA launches policy paper urging Europe to lead on mental health innovation

Next
Next

PAREA at Breaking Convention 2025